Johnson & Johnson posts strong third quarter earnings after pause in coronavirus vaccine study
October 13, 2020 at 11:51 AM EDT
Johnson & Johnson reported a strong third quarter performance on Tuesday following an announcement that it is pausing its coronavirus vaccine research study.
